Michelle Kopp
Physician Assistant · Falls Church, VANPI 1407222946
Payments from drug & device makers
Across 94 payments — averaging $30.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- United Therapeutics Corporation$1K
- Actelion Pharmaceuticals US, Inc.$305
- Takeda Pharmaceuticals U.S.A., Inc.$218
- Melinta Therapeutics, LLC$198
- Boehringer Ingelheim$175
- Sanofi-aventis U.S. LLC$106
- plus $723 from 19 others
What the payments were for
- Food & beverage$2,78297%
- Education$773%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| United Therapeutics Corporation | 30 | $1,135 |
| Actelion Pharmaceuticals US, Inc. | 7 | $305 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $218 |
| Melinta Therapeutics, LLC | 6 | $198 |
| Boehringer Ingelheim | 10 | $175 |
| Sanofi-aventis U.S. LLC | 1 | $106 |
| AbbVie | 4 | $100 |
| Paratek Pharmaceuticals, Inc. | 5 | $99 |
| Astellas Pharma US Inc | 2 | $83 |
| Mylan Specialty L.p. | 3 | $67 |
| Bayer | 2 | $56 |
| Vertex | 2 | $47 |
| Invivyd Inc | 2 | $31 |
| ANI Pharmaceuticals, Inc. | 1 | $31 |
| AstraZeneca | 1 | $22 |
| Verona Pharma, Inc. | 1 | $21 |
| Abiomed | 1 | $20 |
| La Jolla Pharmaceutical Company | 1 | $20 |
| Johnson & Johnson | 1 | $20 |
| Apellis Pharmaceuticals, Inc. | 1 | $20 |
| Baxter Healthcare | 1 | $19 |
| Advanced Respiratory, Inc | 1 | $18 |
| Mallinckrodt Hospital Products Inc. | 1 | $17 |
| CMP Pharma, Inc. | 1 | $17 |
| Philips North America LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,859 in reported general payments places this provider in the 85th percentile of 3,376 physician assistant providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CresembaIsavuconazonium Sulfate | 15 | $81,815 |
| Atovaquone | 15 | $3,470 |
| Tacrolimus | 13 | $2,701 |
| Ampicillin Sodium | 11 | $2,223 |
| Azithromycin | 14 | $260 |
| Prednisone | 46 | $232 |
| Pantoprazole Sodium | 14 | $122 |
| Famotidine | 11 | $73 |
| Mirtazapine | 11 | $63 |
| Furosemide | 11 | $26 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncCresemba | $83 | $81,81515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,376 physician assistant providers in Virginia.
Other physician assistant in Falls Church
- Angela HarnerFalls Church$16K
- James OharaFalls Church$15K
- John DalessandroSalem$160K
- Jalal AlghabraFredericksburg$119K
- Jamie GiovanelliVirginia Beach$118K
- John CarterStaunton$90K
- Melissa AlcoxNorfolk$73K
- Lindsay TomReston$71K
- Robert HigginsonRichmond$66K
- Jameka McElroy-BrooklynArlington$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.